BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32491863)

  • 1. Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.
    Sarkar P; Li Z; Ren W; Wang S; Shao S; Sun J; Ren X; Perkins NG; Guo Z; Chang CA; Song J; Xue M
    J Med Chem; 2020 Jul; 63(13):6979-6990. PubMed ID: 32491863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
    Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD
    FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
    Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
    Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
    Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
    Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis.
    Musso O; Théret N; Campion JP; Turlin B; Milani S; Grappone C; Clément B
    J Hepatol; 1997 Mar; 26(3):593-605. PubMed ID: 9075667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
    Danilewicz M; Sikorska B; Wagrowska-Danilewicz M
    Med Sci Monit; 2003 Mar; 9(3):MT42-7. PubMed ID: 12640351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
    Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
    Hum Pathol; 2008 May; 39(5):731-9. PubMed ID: 18329693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity.
    Bein K; Simons M
    J Biol Chem; 2000 Oct; 275(41):32167-73. PubMed ID: 10900205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
    Fillmore HL; VanMeter TE; Broaddus WC
    J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.
    Deambrosis I; Lamorte S; Giaretta F; Tei L; Biancone L; Bussolati B; Camussi G
    J Mol Med (Berl); 2009 Feb; 87(2):181-97. PubMed ID: 18985310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 mediates stretch-induced activation of skeletal muscle satellite cells in a nitric oxide-dependent manner.
    Yamada M; Sankoda Y; Tatsumi R; Mizunoya W; Ikeuchi Y; Sunagawa K; Allen RE
    Int J Biochem Cell Biol; 2008; 40(10):2183-91. PubMed ID: 18403250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant.
    Eleuterio NM; Palei AC; Rangel Machado JS; Tanus-Santos JE; Cavalli RC; Sandrim VC
    Pregnancy Hypertens; 2015 Apr; 5(2):205-8. PubMed ID: 25943646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2.
    Karagiannis ED; Popel AS
    J Biol Chem; 2004 Sep; 279(37):39105-14. PubMed ID: 15252025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallopeptidase inhibitor TIMP2 participate in maternal preparation of pregnancy.
    Ulbrich SE; Meyer SU; Zitta K; Hiendleder S; Sinowatz F; Bauersachs S; Büttner M; Fröhlich T; Arnold GJ; Reichenbach HD; Wolf E; Meyer HH
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):48-57. PubMed ID: 20887771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
    Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
    Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
    Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
    J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.